◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › R › RMD

ResMed Inc (RMD) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-17

ResMed Inc (RMD) operates in the Health Care Equipment industry and is headquartered in San Diego, United States with about 11,370 employees. Its market capitalization is roughly $32 billion. In the fiscal year ended 2026-06-30, RMD reported $5.7B in revenue and $1.5B in net income.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.

Interactive charts & full statements → Open the RMD valuation workbench →

RMD Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2026-06-30	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30	2015-06-30	2014-06-30	2013-06-30	2012-06-30	2011-06-30	2010-06-30	2009-06-30	2008-06-30	2007-06-30
Total Revenue	$5.7B	$5.7B	$5.1B	$4.7B	$4.2B	$3.6B	$3.2B	$3.0B	$2.6B	$2.3B	$2.1B	$1.8B	$1.7B	$1.6B	$1.5B	$1.4B	$1.2B	$1.1B	$921M	$835M	$716M
Gross Profit	$3.5B	$3.5B	$3.1B	$2.7B	$2.4B	$2.0B	$1.8B	$1.7B	$1.5B	$1.4B	$1.2B	$1.1B	$1.0B	$990M	$941M	$821M	$741M	$655M	$554M	$494M	$384M
Gross Margin %	61.2%	61.2%	59.4%	56.7%	55.8%	56.6%	57.5%	58.1%	59.0%	58.2%	58.1%	58.0%	60.2%	63.6%	62.1%	60.0%	59.6%	60.0%	60.2%	59.1%	53.7%
Operating Income (EBIT)	$1.9B	$1.9B	$1.7B	$1.3B	$1.1B	$1.0B	$904M	$810M	$579M	$542M	$426M	$429M	$409M	$405M	$355M	$294M	$267M	$240M	$190M	$143M	$90M
Operating Margin %	33.5%	33.5%	32.8%	28.2%	26.8%	28.0%	28.3%	27.4%	22.2%	23.2%	20.6%	23.3%	24.4%	26.1%	23.4%	21.5%	21.5%	22.0%	20.7%	17.1%	12.6%
Net Income	$1.5B	$1.5B	$1.4B	$1.0B	$898M	$779M	$475M	$622M	$405M	$316M	$342M	$352M	$353M	$345M	$307M	$255M	$227M	$190M	$146M	$110M	$66M
Net Margin %	26.9%	26.9%	27.2%	21.8%	21.2%	21.8%	14.8%	21.0%	15.5%	13.5%	16.6%	19.2%	21.0%	22.2%	20.3%	18.6%	18.3%	17.4%	15.9%	13.2%	9.3%
EBITDA	$2.1B	$2.1B	$1.9B	$1.5B	$1.4B	$1.2B	$1.1B	$990M	$706M	$680M	$569M	$541M	$482M	$485M	$470M	$423M	$374M	$322M	$190M	$205M	$90M
Earnings Per Share (EPS)	$10.40	$10.51	$9.51	$6.92	$6.09	$5.30	$3.24	$4.27	$2.80	$2.19	$2.40	$2.49	$2.47	$2.39	$2.10	$1.71	$1.44	$1.23	$0.95	$0.70	$0.42
Shares Outstanding (M)	145M	145M	147M	148M	147M	147M	146M	146M	144M	144M	142M	142M	143M	144M	146M	149M	157M	155M	154M	157M	157M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RMD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$1.5B	$1.4B	$1.4B	$1.3B	$1.3B	$1.3B	$1.3B	$1.2B
Gross Profit	$861M	$891M	$885M	$821M	$820M	$766M	$751M	$717M
Gross Margin %	58.8%	62.3%	62.2%	61.5%	60.8%	59.3%	58.6%	58.6%
Operating Income (EBIT)	$449M	$500M	$498M	$447M	$455M	$426M	$417M	$387M
Operating Margin %	30.7%	34.9%	35.0%	33.4%	33.7%	33.0%	32.5%	31.6%
Net Income	$383M	$399M	$393M	$349M	$380M	$365M	$345M	$311M
Net Margin %	26.2%	27.9%	27.6%	26.1%	28.2%	28.3%	26.9%	25.4%
EBITDA	$493M	$584M	$566M	$503M	$532M	$470M	$479M	$443M
Earnings Per Share (EPS)	$2.64	$2.71	$2.67	$2.37	$2.58	$2.48	$2.33	$2.11
Shares Outstanding (M)	145M	147M	147M	147M	147M	147M	148M	148M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RMD Free Cash Flow History

Cash flow	TTM → 2026-06-30	2026-06-30	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30	2015-06-30	2014-06-30	2013-06-30	2012-06-30	2011-06-30	2010-06-30	2009-06-30	2008-06-30	2007-06-30
Cash from Operations (CFO)	$3.2B	$1.8B	$1.8B	$1.4B	$693M	$351M	$737M	$802M	$459M	$505M	$414M	$548M	$383M	$391M	$403M	$383M	$283M	$188M	$239M	$138M	$91M
Capital Expenditures (CapEx)	$267M	$156M	$90M	$115M	$134M	$156M	$117M	$106M	$77M	$71M	$71M	$68M	$72M	$81M	$72M	$61M	$75M	$62M	$114M	$76M	$78M
Free Cash Flow (FCF)	$2.9B	$1.6B	$1.7B	$1.3B	$559M	$195M	$620M	$696M	$382M	$434M	$343M	$480M	$311M	$310M	$331M	$322M	$208M	$127M	$125M	$62M	$14M
FCF Margin %	51.1%	29.2%	32.3%	27.5%	13.2%	5.5%	19.4%	23.5%	14.6%	18.5%	16.6%	26.1%	18.5%	19.9%	21.9%	23.5%	16.8%	11.6%	13.5%	7.4%	1.9%
Dividends Paid	$612M	$350M	$311M	$282M	$258M	$245M	$227M	$225M	$212M	$199M	$186M	$168M	$157M	$142M	$97M	$270M	$98M	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RMD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$1.8B	$554M	$340M	$457M	$539M	$579M	$309M	$326M
Capital Expenditures (CapEx)	$156M	$34M	$35M	$43M	$31M	$24M	$19M	$20M
Free Cash Flow (FCF)	$1.6B	$520M	$305M	$414M	$508M	$555M	$290M	$306M
FCF Margin %	112.7%	36.4%	21.4%	31.0%	37.7%	43.0%	22.6%	25.0%
Dividends Paid	$350M	$87M	$88M	$88M	$78M	$78M	$78M	$78M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RMD Balance Sheet History

Balance sheet	2026-06-30	2026-06-30	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2018-06-30	2017-06-30	2016-06-30	2015-06-30	2014-06-30	2013-06-30	2012-06-30	2011-06-30	2010-06-30	2009-06-30	2008-06-30	2007-06-30
Total Assets	$9.0B	$9.0B	$8.2B	$6.9B	$6.8B	$5.1B	$4.7B	$4.6B	$4.1B	$3.1B	$3.5B	$3.3B	$2.2B	$2.4B	$2.2B	$2.1B	$2.1B	$1.6B	$1.5B	$1.4B	$1.3B
Cash & Cash Equivalents	$1.5B	$1.5B	$1.2B	$238M	$228M	$274M	$295M	$463M	$147M	$189M	$822M	$731M	$717M	$906M	$876M	$810M	$735M	$489M	$416M	$321M	$258M
Total Liabilities	$2.4B	$2.4B	$2.2B	$2.0B	$2.6B	$1.7B	$1.8B	$2.1B	$2.0B	$1.0B	$1.5B	$1.6B	$597M	$603M	$600M	$530M	$338M	$339M	$393M	$324M	$321M
Total Debt (Short + Long-Term)	$689M	$689M	$699M	$732M	$1.5B	$797M	$679M	$1.2B	$1.3B	$281M	$1.3B	$1.2B	$449M	$301M	$301M	$251M	$100M	$122M	$162M	$138M	$116M
Total Shareholders' Equity	$6.6B	$6.6B	$6.0B	$4.9B	$4.1B	$3.4B	$2.9B	$2.5B	$2.1B	$2.1B	$2.0B	$1.7B	$1.6B	$1.8B	$1.6B	$1.6B	$1.7B	$1.3B	$1.1B	$1.1B	$931M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RMD viewer.

RMD Metric Deep Dives

Other Companies in Health Care Equipment

EW · Edwards Lifesciences — $51 billion
BDX · Becton Dickinson — $49 billion
IDXX · Idexx Laboratories — $40 billion
DXCM · Dexcom — $34 billion
GEHC · GE HealthCare — $29 billion
STE · Steris — $20 billion
ZBH · Zimmer Biomet — $18 billion
RVTY · Revvity — $16 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← RMCO All “R” companies RMDRIP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.